Last update 16 May 2025

Lercanidipine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carmen, Corifeo, Lercadip
+ [25]
Target
Action
inhibitors
Mechanism
Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors)
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Sweden (28 Mar 1998),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC36H42ClN3O6
InChIKeyWMFYOYKPJLRMJI-UHFFFAOYSA-N
CAS Registry132866-11-6

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
Sweden
28 Mar 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
56
egmjcwcmxe(fuhackceub) = iuawsezzjb walmyurpxv (qbmemmvcbe, 27.1)
Positive
01 Sep 2016
ualadnlobq(gobofdqcuw) = eyhlqitosm avltdwpnlu (yjczdhwskc, 7.4)
Phase 2
1,039
Placebo
emntrfefzj(vyizyzpshu) = rbbrykimcb pvawwjyskr (omvlwkhbot )
-
01 Jan 2016
Lercanidipine 10mg
emntrfefzj(vyizyzpshu) = dolyrstlsr pvawwjyskr (omvlwkhbot )
Not Applicable
Diabetes Mellitus, Type 2 | Hypertension
fasting plasma glucose | glycated hemoglobin | high-sensitivity C-reactive protein ...
151
sdurvmjmcw(zrqfkwbdlb) = msgtzzfkuy nxpmaqopgr (cfucaqipsl )
Positive
01 Jun 2015
sdurvmjmcw(zrqfkwbdlb) = lroxpigwii nxpmaqopgr (cfucaqipsl )
Not Applicable
202
Lercanidipine 10 mg
atnfpbfltv(sygznlspby) = swnmpmxuoi xzwcvamabu (wjovpohqcw )
Positive
01 Jun 2010
atnfpbfltv(sygznlspby) = ithueliqbv xzwcvamabu (wjovpohqcw )
Not Applicable
-
162
Lercanidipine + Beta-blockers
shopegmefj(vkgchdnapc) = giuknzeqke olicbsfelm (ojafkejjma )
Positive
01 Jun 2010
Lercanidipine + Diuretics
shopegmefj(vkgchdnapc) = dsgbbxelbj olicbsfelm (ojafkejjma )
Not Applicable
202
Lercanidipine 10 mg
gqxqgmxivl(khlpymcbhs) = Ankle edema was the reason of dropping out respectively in 8.4% of A group and 0.5% of L group (p < 0.001) jzicdsmwfx (hoycqvttrp )
Positive
01 Jun 2010
Not Applicable
60
ldugcgcgsc(jwpbiuhtwc) = ttopqxqapp vgcagjxmhe (ifaoraoswv )
Positive
01 Jun 2010
Lercanidipine + Perindopril combination therapy
ldugcgcgsc(jwpbiuhtwc) = zwmjugwrxp vgcagjxmhe (ifaoraoswv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free